Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV‐1‐infected women

Abstract

Use of antenatal PI-based HAART initiated before or during pregnancy was associated with a significantly increased risk of premature delivery at <36 weeks' gestation. The overall crude prematurity rate was 34% (63 of 183; 95% CI 28-42).